• 1
    Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. The burden of disease and injury in Australia 2003. Cat. no. PHE 82. Canberra: Australian Institute for Health and Welfare, 2007.
  • 2
    Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
  • 3
    Colton CW, Manderscheid RW. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006;3:114.
  • 4
    Bernstein SL, Yu S, Post LA, Dziura J, Rigotti NA. Undertreatment of tobacco use relative to other chronic conditions. Am J Public Health 2013;103:E5965.
  • 5
    Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2012;(10):CD008286.
  • 6
    Mendelsohn C. The smoking paradox: why is Australia's biggest killer being neglected?: Australian Medical Association, 2013. Available at: (updated 12 August 2013; accessed August 2013).
  • 7
    Rigotti NA. Strategies to help a smoker who is struggling to quit. JAMA 2012;308:15731580.
  • 8
    Australian Institute of Health and Welfare. Risk factors contributing to chronic disease. Cat No. PHE 157. Canberra: AIHW, 2012.
  • 9
    Chapman S, MacKenzie R. The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 2010;7:e1000216.
  • 10
    Hung WT, Dunlop SM, Perez D, Cotter T. Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. BMC Public Health 2011;11:592.
  • 11
    Reid JL, Hammond D, Boudreau C, Fong GT, Siahpush M. Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res 2010;12(Suppl.):S2033.
  • 12
    Winstanley M, van der Sterren A, Knoche D. Chapter 8. Tobacco use among Aboriginal peoples and Torres Strait Islanders. In: Scollo MM and Winstanley MH , eds. Tobacco in Australia: facts and issues, 4th edn. Melbourne: Cancer Council Victoria, 2012 Section 8.1. Available at: (updated September 2011; cited September 2013).
  • 13
    Richmond RL, Wilhelm KA, Indig D, Butler TG, Archer VA, Wodak AD. Cardiovascular risk among Aboriginal and non-Aboriginal smoking male prisoners: inequalities compared to the wider community. BMC Public Health 2011;11:783.
  • 14
    Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013;346:f2539.
  • 15
    Baker A, Ivers RG, Bowman J, et al. Where there's smoke, there's fire: high prevalence of smoking among some sub-pipulations and recommendations for intervention. Drug Alcohol Rev 2006;25:8596.
  • 16
    Rooke C. Harm reduction and the medicalisation of tobacco use. Sociol Health Illn 2013;35:361376.
  • 17
    Stewart M. Towards a global definition of patient centred care. BMJ 2001;322:444445.
  • 18
    Mirzaei M, Aspin C, Essue B, et al. A patient-centred approach to health service delivery: improving health outcomes for people with chronic illness. BMC Health Serv Res 2013;13:251.
  • 19
    RANZCP. Patient-Centred Care: improving quality and safety by focusing care on patients and consumers. Submission to the Australian Commission on Safety and Quality in Health Care Discussion Paper. Melbourne: The Royal Australia and New Zealand College of Psychiatrists, 2010.
  • 20
    Dwamena F, Holmes-Rovner M, Gaulden CM, et al. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2012;(12):CD003267.
  • 21
    Bardes CL. Defining ‘patient-centered medicine’. N Engl J Med 2012;366:782783.
  • 22
    Lewin S, Skea Z, Entwistle VA, Zwarenstein M, Dick J Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database Syst Rev 2001;(4):CD003267.
  • 23
    Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR. Patient-centered medicine: transforming the clinical method, Second edn. Abingdon: Radcliffe Medical Press, 2003.
  • 24
    Borland R, Yong H-H, Balmford J, et al. Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine Tob Res 2010;12(Suppl. 1):S411.
  • 25
    Aveyard P, West R. Managing smoking cessation. BMJ 2007;335:3741.
  • 26
    Pisinger C, Vestbo J, Borch-Johnsen K, Jørgensen T. It is possible to help smokers in early motivational stages to quit: the Inter99 study. Prev Med 2005;40:278284.
  • 27
    Beard E, Michie S, Fidler J, West R. Use of nicotine replacement therapy in situations involving temporary abstinence from smoking: a national survey of English smokers. Addict Behav 2013;38:18761879.
  • 28
    Hughes JR, Carpenter MJ. Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine Tob Res 2006;8:739749.
  • 29
    Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction 2005;100:10741089.
  • 30
    NICE. Tobacco: harm-reduction approaches to smoking: NICE public health guidance 45. National Institute for Health and Care Excellence (NICE), 2013.
  • 31
    Beard E, Aveyard P, Brown J, West R. Assessing the association between the use of NRT for smoking reduction and attempts to quit smoking using propensity score matching. Drug Alcohol Depend 2012;126:354361.
  • 32
    Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 2008;12:iiiiv, ix–xi, 1–135.
  • 33
    Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-analysis. BMJ 2009;338:b1024.
  • 34
    Lindson-Hawley N, Aveyard P, Hughes JR. Gradual reduction vs abrupt cessation as a smoking cessation strategy in smokers who want to quit. JAMA 2013;310:9192.
  • 35
    Rose JE. Nicotine preloading: the importance of a pre-cessation reduction in smoking behavior. Psychopharmacology (Berl) 2011;217:453454.
  • 36
    Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med 2011;171:19011907.
  • 37
    Hughes JR, Rennard SI, Fingar JR, Talbot SK, Callas PW, Fagerstrom KO. Efficacy of Varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial. Nicotine Tob Res 2011;13:955964.
  • 38
    Asfar T, Ebbert JO, Klesges RC, Relyea GE. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav 2011;36:764768.
  • 39
    Baker TB, Piper ME, McCarthy DE, et al. Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res 2007;9(Suppl. 4):S555570.
  • 40
    Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev 2012;(12):CD009670.
  • 41
    Partos TR, Borland R, Yong H-H, Hyland A, Cummings KM. The quitting rollercoaster: how recent quitting history affects future cessation outcomes (Data From the International Tobacco Control 4-Country Cohort Study). Nicotine Tob Res 2013;15:15781587.
  • 42
    Zwar N, Richmond R, Borland R, et al. Supporting smoking cessation: a guide for health professionals. Melbourne: The Royal Australian College of General Practitioners, 2011.
  • 43
    Bittoun R. A combination nicotine replacement therapy (NRT) Algorithm for hard-to-treat smokers. J Smok Cessat 2006;1:36.
  • 44
    Mendelsohn C. Optimising nicotine replacement therapy in clinical practice. Aust Fam Physician 2013;42:305309.
  • 45
    Tsoi D, Porwal M, Webster AC. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2010;196:346353.
  • 46
    Ebbert JO, Burke MV, Hays JT, Hurt RD. Combination treatment with varenicline and nicotine replacement therapy. Nicotine Tob Res 2009;11:572576.
  • 47
    Brose LS, West R, Stapleton JA. Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice. Mayo Clin Proc 2013;88:226233.
  • 48
    Bittoun R. Carbon monoxide meter: the essential clinical tool- the ‘stethoscope'-of smoking cessation. J Smoking Cessation 2008;3:6970.
  • 49
    McClure JB. Are biomarkers useful treatment aids for promoting health behavior change?: an empirical review. Am J Prev Med 2002;22:200207.
  • 50
    Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2004;13:18001804.
  • 51
    Metrik J, Spillane NS, Leventhal AM, Kahler CW. Marijuana use and tobacco smoking cessation among heavy alcohol drinkers. Drug Alcohol Depend 2011;119:194200.
  • 52
    van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database Syst Rev 2013;(8):CD006102.